INMB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 36.10%

Insider Buying (Last 12 Months): $64,700.00

Insider Selling (Last 12 Months): $110,100.00

INmune Bio Insider Trading History Chart

INmune Bio Share Price & Price History

^$10.81

▲ +0.66 (6.50%)

As of 12/8/2023 09:57 PM ET

Days: 30 | 90 | 365

The Battery Metal Nobody Told You About

From Edge On The Street | Ad

According to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy.

Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech."

See why investors are taking a hard look

INmune Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/10/2023	Scott Juda	Director	Buy	7,000	$6.95	$48,650.00	37,000
7/12/2023	Timothy J. Schroeder	Director	Sell	10,000	$11.01	$110,100.00	82,187
3/17/2023	David J. Moss	CFO	Buy	2,500	$6.42	$16,050.00	1,250,151
5/26/2022	David J. Moss	CFO	Buy	7,700	$6.27	$48,279.00	1,244,651
5/26/2022	Raymond Joseph Tesi	CEO	Buy	6,300	$6.41	$40,383.00	1,520,698
11/3/2021	David J. Moss	CFO	Sell	1,025	$20.00	$20,500.00
11/3/2021	Mark William Lowdell	Insider	Sell	701	$20.00	$14,020.00
11/3/2021	Raymond Joseph Tesi	CEO	Sell	3,626	$20.00	$72,520.00
10/27/2021	David J. Moss	CFO	Sell	2,079	$20.00	$41,580.00
10/27/2021	Mark William Lowdell	Insider	Sell	2,357	$20.00	$47,140.00
10/27/2021	Raymond Joseph Tesi	CEO	Sell	6,517	$20.00	$130,340.00
10/25/2021	David J. Moss	CFO	Sell	13	$20.00	$260.00
10/22/2021	David J. Moss	CFO	Sell	1,142	$20.00	$22,840.00
10/22/2021	Mark William Lowdell	Insider	Sell	400	$20.00	$8,000.00
10/22/2021	Raymond Joseph Tesi	CEO	Sell	23,616	$20.00	$472,320.00
7/13/2021	Timothy J. Schroeder	Director	Sell	14,480	$27.63	$400,082.40
7/9/2021	Timothy J. Schroeder	Director	Sell	30,000	$23.20	$696,000.00
7/7/2021	David J. Moss	CFO	Sell	8,698	$20.01	$174,046.98
7/7/2021	Mark William Lowdell	Insider	Sell	5,850	$20.02	$117,117.00	1,500,401
7/7/2021	Raymond Joseph Tesi	CEO	Sell	5,649	$20.02	$113,092.98	1,535,284
6/14/2021	Timothy J. Schroeder	Director	Sell	10,000	$19.02	$190,200.00

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for INmune Bio (NASDAQ:INMB)

12.13% of INmune Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

INmune Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/24/2023	Deutsche Bank AG	109,848	$0.74M	0.0%	-9.3%	0.610%
11/15/2023	Royal Bank of Canada	72,683	$0.49M	0.0%	+3.4%	0.403%
11/13/2023	LPL Financial LLC	10,097	$68K	0.0%	N/A	0.056%
11/9/2023	Rhenman & Partners Asset Management AB	50,000	$0.34M	0.0%	-72.0%	0.277%
11/9/2023	Deutsche Bank AG	109,848	$0.74M	0.0%	-9.3%	0.610%
11/9/2023	UBS Group AG	41,850	$0.28M	0.0%	-19.9%	0.232%
11/8/2023	Janney Montgomery Scott LLC	256,887	$1.74M	0.0%	+14.5%	1.426%
11/7/2023	Fermata Advisors LLC	56,702	$0.38M	0.1%	N/A	0.315%
10/24/2023	Bank of New York Mellon Corp	32,891	$0.22M	0.0%	N/A	0.183%
8/21/2023	Osaic Holdings Inc.	11,200	$0.10M	0.0%	+41.1%	0.062%
8/15/2023	Royal Bank of Canada	70,308	$0.64M	0.0%	+16.1%	0.390%
8/11/2023	Renaissance Technologies LLC	20,000	$0.18M	0.0%	-42.5%	0.111%
8/11/2023	BlackRock Inc.	239,633	$2.18M	0.0%	+2.1%	1.330%
8/11/2023	Geode Capital Management LLC	154,680	$1.40M	0.0%	+7.7%	0.858%
8/11/2023	Rhenman & Partners Asset Management AB	178,284	$1.62M	0.2%	N/A	0.989%
8/10/2023	Osaic Holdings Inc.	11,200	$0.10M	0.0%	+41.1%	0.062%
8/2/2023	MAI Capital Management	59,177	$0.54M	0.0%	+201.3%	0.330%
7/26/2023	Janney Montgomery Scott LLC	224,405	$2.04M	0.0%	-6.3%	1.250%
7/24/2023	Meitav Investment House Ltd.	181,140	$6.65M	0.1%	N/A	1.009%
7/14/2023	Westside Investment Management Inc.	42,240	$0.38M	0.1%	+13.8%	0.235%
5/17/2023	Westside Investment Management Inc.	37,105	$0.24M	0.1%	+22.1%	0.207%
5/16/2023	Susquehanna International Group LLP	70,637	$0.46M	0.0%	+189.6%	0.394%
5/16/2023	Squarepoint Ops LLC	13,045	$84K	0.0%	N/A	0.073%
5/12/2023	Renaissance Technologies LLC	34,800	$0.23M	0.0%	N/A	0.194%
5/12/2023	Bank of America Corp DE	4,717	$30K	0.0%	+152.1%	0.026%
5/12/2023	UBS Group AG	53,644	$0.35M	0.0%	+19.1%	0.299%
5/11/2023	Financial Advocates Investment Management	11,500	$74K	0.0%	-15.8%	0.064%
5/10/2023	MAI Capital Management	19,643	$0.13M	0.0%	N/A	0.109%
4/28/2023	Janney Montgomery Scott LLC	239,448	$1.55M	0.0%	+6.6%	1.334%
2/16/2023	Financial Advocates Investment Management	13,651	$87K	0.0%	N/A	0.076%
2/15/2023	Millennium Management LLC	16,632	$0.11M	0.0%	-38.8%	0.093%
2/13/2023	Wells Fargo & Company MN	7,603	$48K	0.0%	-40.0%	0.042%
2/13/2023	Geode Capital Management LLC	142,997	$0.91M	0.0%	+2.4%	0.797%
2/10/2023	Advisor Group Holdings Inc.	9,250	$59K	0.0%	+52.9%	0.052%
2/8/2023	UBS Group AG	45,030	$0.29M	0.0%	+12.7%	0.251%
2/3/2023	Sepio Capital LP	23,200	$0.15M	0.0%	-4.9%	0.129%
2/1/2023	Janney Montgomery Scott LLC	224,579	$1.42M	0.0%	+14.9%	1.251%
11/15/2022	Vanguard Group Inc.	541,398	$3.36M	0.0%	-2.2%	3.017%
11/14/2022	Royal Bank of Canada	60,528	$0.38M	0.0%	+2.8%	0.337%
11/10/2022	Tower Research Capital LLC TRC	3,909	$25K	0.0%	N/A	0.022%
11/3/2022	ACT Capital Management LLC	151,100	$0.94M	1.3%	-5.9%	0.842%
10/28/2022	Sepio Capital LP	24,400	$0.15M	0.0%	+10.9%	0.136%
10/25/2022	Janney Montgomery Scott LLC	195,486	$1.21M	0.0%	-7.5%	1.089%
8/15/2022	State Street Corp	44,963	$0.40M	0.0%	+19.4%	0.251%
8/13/2022	Renaissance Technologies LLC	32,100	$0.28M	0.0%	N/A	0.179%
8/11/2022	Deutsche Bank AG	121,048	$1.07M	0.0%	+14.1%	0.674%
8/11/2022	UBS Group AG	38,950	$0.34M	0.0%	+8.3%	0.217%
8/9/2022	Fermata Advisors LLC	24,011	$0.21M	0.1%	+22.6%	0.134%
8/4/2022	Northwestern Mutual Wealth Management Co.	4,300	$38K	0.0%	N/A	0.024%
8/3/2022	Janney Montgomery Scott LLC	211,318	$1.73M	0.0%	-18.9%	1.177%
7/26/2022	Sepio Capital LP	22,000	$0.19M	0.0%	N/A	0.123%
7/15/2022	Westside Investment Management Inc.	30,140	$0.27M	0.0%	+14.2%	0.168%
5/17/2022	Royal Bank of Canada	51,606	$0.43M	0.0%	+17.2%	0.287%
5/16/2022	State Street Corp	37,663	$0.32M	0.0%	+11.4%	0.210%
5/13/2022	Vanguard Group Inc.	553,638	$4.66M	0.0%	+8.3%	3.084%
5/4/2022	Advisor Group Holdings Inc.	33,100	$0.28M	0.0%	-7.4%	0.185%
4/25/2022	Westside Investment Management Inc.	26,390	$0.22M	0.0%	+238.3%	0.148%
4/22/2022	Fermata Advisors LLC	19,586	$0.17M	0.1%	+9.1%	0.110%
2/15/2022	Westside Investment Management Inc.	7,800	$79K	0.0%	N/A	0.044%
2/9/2022	Alps Advisors Inc.	20,650	$0.21M	0.0%	-4.8%	0.116%
2/3/2022	Advisor Group Holdings Inc.	35,738	$0.36M	0.0%	+193.7%	0.200%
2/3/2022	ACT Capital Management LLC	230,500	$2.35M	1.7%	-16.2%	1.292%
2/2/2022	Fermata Advisors LLC	17,955	$0.18M	0.1%	+39.9%	0.101%
1/27/2022	Janney Montgomery Scott LLC	113,914	$1.16M	0.0%	+14.7%	0.638%
11/16/2021	Migdal Insurance & Financial Holdings Ltd.	1,608	$31K	0.0%	N/A	0.009%
11/16/2021	ACT Capital L.L.C.	275,000	$5.34M	2.8%	N/A	1.541%
11/16/2021	Millennium Management LLC	123,511	$2.40M	0.0%	N/A	0.692%
11/15/2021	Cubist Systematic Strategies LLC	19,989	$0.39M	0.0%	N/A	0.112%
11/15/2021	Marshall Wace LLP	64,650	$1.26M	0.0%	N/A	0.362%
11/15/2021	Royal Bank of Canada	126,411	$2.46M	0.0%	+90.2%	0.708%
11/12/2021	Geode Capital Management LLC	89,607	$1.74M	0.0%	+21.4%	0.502%
11/12/2021	DG Capital Management LLC	20,000	$0.39M	0.1%	N/A	0.112%
11/9/2021	BlackRock Inc.	146,429	$2.84M	0.0%	-20.4%	0.821%
11/5/2021	Advisor Group Holdings Inc.	12,170	$0.24M	0.0%	-55.4%	0.068%
11/4/2021	Financial Advocates Investment Management	16,667	$0.32M	0.0%	-15.3%	0.093%
10/29/2021	Fermata Advisors LLC	12,830	$0.25M	0.1%	+9.2%	0.072%
10/29/2021	Janney Montgomery Scott LLC	99,323	$1.93M	0.0%	+73.2%	0.557%
10/19/2021	Belvedere Trading LLC	16,177	$0.30M	0.0%	-42.2%	0.091%
9/17/2021	Virtu Financial LLC	10,530	$0.19M	0.0%	N/A	0.059%
8/18/2021	Ikarian Capital LLC	146,883	$2.58M	0.2%	-37.1%	0.830%
8/17/2021	Boothbay Fund Management LLC	24,158	$0.42M	0.0%	-24.7%	0.136%
8/16/2021	Royal Bank of Canada	66,458	$1.17M	0.0%	+1.4%	0.375%
8/16/2021	Morgan Stanley	11,543	$0.20M	0.0%	+273.2%	0.065%
8/16/2021	State Street Corp	34,816	$0.61M	0.0%	N/A	0.197%
8/13/2021	Altium Capital Management LP	52,257	$0.92M	0.2%	N/A	0.295%
8/13/2021	Geode Capital Management LLC	73,794	$1.30M	0.0%	+21.3%	0.417%
8/13/2021	Vanguard Group Inc.	379,168	$6.66M	0.0%	+21.1%	2.142%
8/13/2021	EAM Global Investors LLC	116,809	$2.05M	0.6%	N/A	0.660%
8/13/2021	EAM Investors LLC	161,793	$2.84M	0.4%	N/A	0.914%
8/12/2021	Advisory Services Network LLC	3,108	$55K	0.0%	N/A	0.018%
8/11/2021	BlackRock Inc.	184,006	$3.23M	0.0%	-16.3%	1.039%
8/11/2021	Susquehanna International Group LLP	75,714	$1.33M	0.0%	+128.9%	0.428%
8/10/2021	Fermata Advisors LLC	11,750	$0.21M	0.1%	N/A	0.066%
8/2/2021	Advisor Group Holdings Inc.	27,262	$0.48M	0.0%	+241.5%	0.172%
7/31/2021	Marino Stram & Associates LLC	10,369	$0.18M	0.0%	N/A	0.065%
5/18/2021	Millennium Management LLC	41,988	$0.50M	0.0%	N/A	0.281%
5/18/2021	Jane Street Group LLC	12,221	$0.15M	0.0%	N/A	0.082%
5/17/2021	Royal Bank of Canada	65,548	$0.78M	0.0%	+15.0%	0.439%
5/17/2021	HRT Financial LP	22,055	$0.26M	0.0%	N/A	0.148%
5/17/2021	Ikarian Capital LLC	233,576	$2.78M	0.1%	+7.4%	1.564%

Data available starting January 2016

INmune Bio, Inc., a clinical-stage immunology company, focuses on reprogramming the patient's innate immune system to treat cancer and neurodegenerative diseases. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma solid tumor and patients with high-risk myelodysplastic syndrome; INB03 to treat patients with cancers that express MUC4, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers; and XPro1595 for the treatment of Alzheimer's disease and Treatment Resistant Depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.

Today's Range

Now: $10.81

$10.07

$11.00

50 Day Range

MA: $7.72

$6.60

$10.81

52 Week Range

Now: $10.81

$5.87

$11.26

Volume

158,500 shs

Average Volume

51,198 shs

Market Capitalization

$194.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.01

Who are the company insiders with the largest holdings of INmune Bio?: INmune Bio's top insider shareholders include:
Raymond Joseph Tesi (CEO)
David J Moss (CFO)
Timothy J Schroeder (Director)
Scott Juda (Director)
Learn More about top insider investors at INmune Bio.
Who are the major institutional investors of INmune Bio?: INmune Bio's top institutional investors include:
Janney Montgomery Scott LLC — 1.43%
Deutsche Bank AG — 0.61%
Deutsche Bank AG — 0.61%
Royal Bank of Canada — 0.40%
Fermata Advisors LLC — 0.31%
Rhenman & Partners Asset Management AB — 0.28%
Learn More about top institutional investors of INmune Bio stock.
Which institutional investors are selling INmune Bio stock?: Within the previous quarter, INMB stock was sold by these institutional investors:
Rhenman & Partners Asset Management AB
Deutsche Bank AG
Deutsche Bank AG
UBS Group AG
Which institutional investors are buying INmune Bio stock?: Within the last quarter, INMB stock was purchased by institutional investors including:
Fermata Advisors LLC
Bank of New York Mellon Corp
Janney Montgomery Scott LLC
LPL Financial LLC
Simplex Trading LLC
Royal Bank of Canada
Within the last year, these company insiders have bought INmune Bio stock:
Raymond Joseph Tesi (CEO)
David J Moss (CFO)
Timothy J Schroeder (Director)
Learn More investors buying INmune Bio stock.